ALPS Group, Inc. (ALPS)
0.385
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 16:00
ALPS Group Total Assets (Quarterly) : 1.740M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 1.740M |
| June 30, 2025 | 3.797M |
| March 31, 2025 | 3.615M |
| December 31, 2024 | 4.263M |
| September 30, 2024 | 29.94M |
| June 30, 2024 | 29.56M |
| March 31, 2024 | 29.19M |
| December 31, 2023 | 29.24M |
| September 30, 2023 | 51.61M |
| Date | Value |
|---|---|
| June 30, 2023 | 50.95M |
| March 31, 2023 | 120.21M |
| December 31, 2022 | 118.78M |
| September 30, 2022 | 118.02M |
| June 30, 2022 | 117.74M |
| March 31, 2022 | 117.76M |
| December 31, 2021 | 117.96M |
| September 30, 2021 | 0.1188M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bio Green Med Solution, Inc. | 7.854M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Agenus, Inc. | 172.69M |
| Alkermes Plc | 4.393B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.97M |
| Shareholders Equity (Quarterly) | -11.23M |